Your session is about to expire
← Back to Search
Ultrasound
Active Ultrasound Device for Osteoarthritis
N/A
Waitlist Available
Research Sponsored by ZetrOZ, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Are you between 35 and 80 years of age (inclusive)?
Can you speak, read, and write in English?
Timeline
Screening 3 weeks
Treatment Varies
Follow Up first week (start of study) to 24 weeks (end of study)
Awards & highlights
Study Summary
This study will measure the 24-week pain relief from long-duration ultrasound on the symptoms of knee arthritis pain.
Eligible Conditions
- Osteoarthritis
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ first week (start of study) to 24 weeks (end of study)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~first week (start of study) to 24 weeks (end of study)
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in Pain Units on a Numeric Rating Scale (NRS)
Secondary outcome measures
Function
Range of motion
Strengthen
Trial Design
2Treatment groups
Active Control
Placebo Group
Group I: Active Ultrasound DeviceActive Control1 Intervention
Active treatment
Group II: Sham Ultrasound DevicePlacebo Group1 Intervention
No ultrasound treatment
Find a Location
Who is running the clinical trial?
ZetrOZ, Inc.Lead Sponsor
15 Previous Clinical Trials
1,165 Total Patients Enrolled
7 Trials studying Osteoarthritis
732 Patients Enrolled for Osteoarthritis
Ralph Ortiz, MPH, DOStudy DirectorMedical Pain Consultants
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger